BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

GRIMES & COMPANY, INC.'s Holding History (CIK: 0001321993)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 37,952 Value ($000) $296 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 53,963 Value ($000) $410 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 53,474 Value ($000) $479 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 72,707 Value ($000) $545 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 75,275 Value ($000) $566 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 75,275 Value ($000) $572 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 75,275 Value ($000) $465 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 71,439 Value ($000) $363 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 72,355 Value ($000) $433 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 73,575 Value ($000) $521 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 72,672 Value ($000) $512 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 72,322 Value ($000) $603 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 71,907 Value ($000) $825 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 71,947 Value ($000) $907 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 70,999 Value ($000) $751 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 68,761 Value ($000) $1,118 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 65,472 Value ($000) $907 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 52,671 Value ($000) $757 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 50,605 Value ($000) $800 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 51,762 Value ($000) $526 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 35,950 Value ($000) $268 Avg Close $5.16 Range $3.36 - $8.99
Q3 2020
Shares 15,000 Value ($000) $52 Avg Close $4.29 Range $3.30 - $6.03